Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06482177 · ClinicalTrials.gov registry record · Phase 4
The COAT Trial: Cequa's Onset of Action Trial
A Phase 4 study, sponsored by Research Insight.
- Completed
- Registry status
- Phase 4
- Development phase
- 52
- Enrollment target
NCT06482177 is a Phase 4 study that has completed, run by Research Insight. The registered enrollment target is 52 participants.
The verdict
NCT06482177, a Phase 4 study, has completed, sponsored by Research Insight.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 52 participants
- Enrollment target
Study Summary
Cequa's Onset of Action Trial: an Investigation of CEQUA's Speed of Onset in Improving Ocular Surface Health in Dry Eye Patients
Interventions
- DRUG Cyclosporine ophthalmic solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2023-10-12 |
| Est. Completion | 2024-06-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06482177
The ClinicalTrials.gov registry entry for NCT06482177 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Research Insight, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cyclosporine ophthalmic solution is the first listed.
NCT06482177 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06482177 about?
NCT06482177 is a clinical study titled "The COAT Trial: Cequa's Onset of Action Trial". Cequa's Onset of Action Trial: an Investigation of CEQUA's Speed of Onset in Improving Ocular Surface Health in Dry Eye Patients
What is the current status of trial NCT06482177?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 52 participants. The study started on 2023-10-12. Estimated completion is 2024-06-05.
What interventions are being tested in trial NCT06482177?
The interventions under investigation include: Cyclosporine ophthalmic solution (DRUG).
Who is sponsoring clinical trial NCT06482177?
This trial is sponsored by Research Insight, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.